Easton Pharmaceutica Stock Current Liabilities
Easton Pharmaceutica fundamentals help investors to digest information that contributes to Easton Pharmaceutica's financial success or failures. It also enables traders to predict the movement of Easton Stock. The fundamental analysis module provides a way to measure Easton Pharmaceutica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Easton Pharmaceutica stock.
The Easton Pharmaceutica's current Non Current Liabilities Total is estimated to increase to about 5 M, while Total Current Liabilities is projected to decrease to under 557.7 K. Easton | Current Liabilities |
Easton Pharmaceutica Company Current Liabilities Analysis
Easton Pharmaceutica's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Easton Pharmaceutica Current Liabilities | 137 K |
Most of Easton Pharmaceutica's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Easton Pharmaceutica is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Easton Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Easton Pharmaceutica is extremely important. It helps to project a fair market value of Easton Stock properly, considering its historical fundamentals such as Current Liabilities. Since Easton Pharmaceutica's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Easton Pharmaceutica's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Easton Pharmaceutica's interrelated accounts and indicators.
Click cells to compare fundamentals
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
Easton Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Easton Pharmaceutica has a Current Liabilities of 137 K. This is 99.99% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Easton Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Easton Pharmaceutica's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Easton Pharmaceutica could also be used in its relative valuation, which is a method of valuing Easton Pharmaceutica by comparing valuation metrics of similar companies.Easton Pharmaceutica is currently under evaluation in current liabilities category among related companies.
Easton Fundamentals
Return On Equity | -0.0269 | ||||
Return On Asset | -0.0083 | ||||
Current Valuation | 2.14 M | ||||
Shares Outstanding | 1.34 B | ||||
Price To Earning | (22.00) X | ||||
Price To Book | 0 X | ||||
Price To Sales | 0.06 X | ||||
Gross Profit | 201.4 K | ||||
EBITDA | (188.54 K) | ||||
Net Income | (188.54 K) | ||||
Cash And Equivalents | 5.81 K | ||||
Total Debt | 2.48 M | ||||
Debt To Equity | 0.43 % | ||||
Current Ratio | 0.69 X | ||||
Book Value Per Share | 0.01 X | ||||
Cash Flow From Operations | (188.54 K) | ||||
Beta | -6.1 | ||||
Market Capitalization | 1.34 K | ||||
Total Asset | 10.19 M | ||||
Retained Earnings | (39.82 M) | ||||
Working Capital | (194.5 K) | ||||
Current Asset | 297 K | ||||
Current Liabilities | 137 K | ||||
Net Asset | 10.19 M |
About Easton Pharmaceutica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Easton Pharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Easton Pharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Easton Pharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Easton Pharmaceutica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Easton Pharmaceutica's short interest history, or implied volatility extrapolated from Easton Pharmaceutica options trading.
Pair Trading with Easton Pharmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Easton Pharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easton Pharmaceutica will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Easton Pharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Easton Pharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Easton Pharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Easton Pharmaceutica to buy it.
The correlation of Easton Pharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Easton Pharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Easton Pharmaceutica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Easton Pharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Easton Pharmaceutica Piotroski F Score and Easton Pharmaceutica Altman Z Score analysis. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Easton Stock analysis
When running Easton Pharmaceutica's price analysis, check to measure Easton Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easton Pharmaceutica is operating at the current time. Most of Easton Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Easton Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easton Pharmaceutica's price. Additionally, you may evaluate how the addition of Easton Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Stocks Directory Find actively traded stocks across global markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Easton Pharmaceutica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Return On Assets (0.01) | Return On Equity (0.03) |
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.